twoXAR Overview
- Founded
- 2014

- Status
- Private
- Employees
- 21

- Latest Deal Type
- Later Stage VC
- Investors
- 9
twoXAR General Information
Description
Operator of an artificial intelligence-driven drug discovery company intended to build a pipeline of therapeutic candidates. The company's firm leverage a computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies and progresses drug candidates to the clinic through industry and investor partnerships, enabling pharmaceutical companies to boost the traditional methods of drug discovery for rare diseases.
Contact Information
- 265 Cambridge Avenue
- Suite 60099
- Palo Alto, CA 94306
- United States
twoXAR Timeline
twoXAR Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC | 23-Dec-2020 | 000.00 | Completed | Generating Revenue | ||
5. Debt - PPP | 16-Apr-2020 | 000.00 | Completed | Pre-Clinical Trials | ||
4. Grant | 28-Nov-2018 | 00000 | 000.00 | Completed | Pre-Clinical Trials | |
3. Early Stage VC (Series A) | 19-Mar-2018 | 0000 | 000.00 | 0000 | Completed | Pre-Clinical Trials |
2. Seed Round | 06-Nov-2015 | $4.31M | $4.31M | 000.00 | Completed | Pre-Clinical Trials |
1. Accelerator/Incubator | 24-Jun-2015 | Completed | Pre-Clinical Trials |
twoXAR Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
twoXAR Comparisons
Industry
00000 00
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialtwoXAR Competitors (33)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Lixte Biotechnology Holdings | Corporation | NY | 0 | 00.000 | 00000000 | 00.000 |
0000000 | Venture Capital-Backed | Toronto, Canada | 00 | 000.00 | 00000 | 000.00 |
0000000 | Venture Capital-Backed | San Mateo, CA | 0 | 00.000 | 00000000000 | 00.000 |
0000000 | Corporation | Branford, CT | ||||
00 000000000000 | Venture Capital-Backed | Guilford, CT | 00 | 0000 | 000000000 - | 0000 |
twoXAR Executive Team (7)
twoXAR Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Andrew Radin | twoXAR | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Brian Moriarty | twoXAR | Chief Financial Officer & Board Member | 000 0000 |
Howard Rosen | Self | Board Member | 000 0000 |
Joonpyo Lee | SoftBank Ventures Asia | Board Member | 000 0000 |
Jorge Conde | Andreessen Horowitz | Board Member | 000 0000 |
twoXAR Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialtwoXAR Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
Haya Ghanim | Angel (individual) | Minority | 000 0000 | 000000 0 | |
OS Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
SoftBank Ventures Asia | Venture Capital | Minority | 000 0000 | 000000 0 |